Literature DB >> 29577925

The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 1-Background, Design Considerations, and Model Development.

David M Shahian1, Jeffrey P Jacobs2, Vinay Badhwar3, Paul A Kurlansky4, Anthony P Furnary5, Joseph C Cleveland6, Kevin W Lobdell7, Christina Vassileva8, Moritz C Wyler von Ballmoos9, Vinod H Thourani10, J Scott Rankin3, James R Edgerton11, Richard S D'Agostino12, Nimesh D Desai13, Liqi Feng14, Xia He14, Sean M O'Brien14.   

Abstract

BACKGROUND: The last published version of The Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) risk models were developed in 2008 based on patient data from 2002 to 2006 and have been periodically recalibrated. In response to evolving changes in patient characteristics, risk profiles, surgical practice, and outcomes, the STS has now developed a set of entirely new risk models for adult cardiac surgery.
METHODS: New models were estimated for isolated coronary artery bypass grafting surgery (CABG [n = 439,092]), isolated aortic or mitral valve surgery (n = 150,150), and combined valve plus CABG procedures (n = 81,588). The development set was based on July 2011 to June 2014 STS ACSD data; validation was performed using July 2014 to December 2016 data. Separate models were developed for operative mortality, stroke, renal failure, prolonged ventilation, reoperation, composite major morbidity or mortality, and prolonged or short postoperative length of stay. Because of its low occurrence rate, a combined model incorporating all operative types was developed for deep sternal wound infection/mediastinitis.
RESULTS: Calibration was excellent except for the deep sternal wound infection/mediastinitis model, which slightly underestimated risk because of higher rates of this endpoint in the more recent validation data; this will be recalibrated in each feedback report. Discrimination (c-index) of all models was superior to that of 2008 models except for the stroke model for valve patients.
CONCLUSIONS: Completely new STS ACSD risk models have been developed based on contemporary patient data; their performance is superior to that of previous STS ACSD models.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29577925     DOI: 10.1016/j.athoracsur.2018.03.002

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  44 in total

Review 1.  Coronary Revascularization in High-Risk Stable Patients With Significant Comorbidities: Challenges in Decision-Making.

Authors:  Joshua Schulman-Marcus; Kellsey Peterson; Riju Banerjee; Sanjay Samy; Neil Yager
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-02-09

2.  Comparison of European System for Cardiac Operative Risk Evaluation (EuroSCORE) and the Society of Thoracic Surgeons(STS) score for risk prediction in Indian patients undergoing coronary artery bypass grafting.

Authors:  Sufina Shales; Sukamanchi Uma Maheswara Rao; Swanand Khapli; Paramita Auddya Ghorai; Sukanta Kumar Behera; Arup Kumar Ghosh; Pradeep Narayan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-05-26

3.  Postoperative Complications Are Not Elevated in Well-Compensated ESRD Patients Undergoing Cardiac Surgery: End-Stage Renal Disease Cardiac Surgery Outcomes.

Authors:  Benjamin R Griffin; Patrick D Kohtz; Michael Bronsert; T Brett Reece; Joseph C Cleveland; David A Fullerton; Sarah Faubel; Muhammad Aftab
Journal:  J Surg Res       Date:  2019-11-27       Impact factor: 2.192

4.  Performance Comparison Between SURPAS and ACS NSQIP Surgical Risk Calculator in Pulmonary Resection.

Authors:  Neel P Chudgar; Shi Yan; Meier Hsu; Kay See Tan; Katherine D Gray; Daniela Molena; Tamar Nobel; Prasad S Adusumilli; Manjit Bains; Robert J Downey; James Huang; Bernard J Park; Gaetano Rocco; Valerie W Rusch; Smita Sihag; David R Jones; James M Isbell
Journal:  Ann Thorac Surg       Date:  2020-10-16       Impact factor: 4.330

5.  Prediction of operative mortality for patients undergoing cardiac surgical procedures without established risk scores.

Authors:  Chin Siang Ong; Erik Reinertsen; Haoqi Sun; Philicia Moonsamy; Navyatha Mohan; Masaki Funamoto; Tsuyoshi Kaneko; Prem S Shekar; Stefano Schena; Jennifer S Lawton; David A D'Alessandro; M Brandon Westover; Aaron D Aguirre; Thoralf M Sundt
Journal:  J Thorac Cardiovasc Surg       Date:  2021-09-14       Impact factor: 5.209

6.  Comparison of SYNTAX score strata effects of percutaneous and surgical revascularization trials: A meta-analysis.

Authors:  Mario Gaudino; Irbaz Hameed; Antonino Di Franco; Ajita Naik; Michelle Demetres; Giuseppe Biondi-Zoccai; Sripal Bangalore
Journal:  J Thorac Cardiovasc Surg       Date:  2021-06-02       Impact factor: 5.209

7.  High-Risk Committee for Cardiac Surgery Decision-Making: Results From 110 Consecutive Patients.

Authors:  Lauren V Huckaby; Thomas G Gleason; Francis D Ferdinand; Ibrahim Sultan; Danny Chu; Pyongsoo Yoon; Forozan Navid; Siva Venkata; David West; Claudio Lima; Victor Morell; Shangzhen Chen; Floyd Thoma; Sasha Drew; Arman Kilic
Journal:  Ann Thorac Surg       Date:  2020-10-27       Impact factor: 4.330

8.  White Blood Cell and Platelet Dynamics Define Human Inflammatory Recovery.

Authors:  Brody H Foy; Thor Sundt; Jonathan C T Carlson; Aaron D Aguirre; John M Higgins
Journal:  medRxiv       Date:  2021-06-23

9.  Toward Dynamic Risk Prediction of Outcomes After Coronary Artery Bypass Graft: Improving Risk Prediction With Intraoperative Events Using Gradient Boosting.

Authors:  Makoto Mori; Thomas J S Durant; Chenxi Huang; Bobak J Mortazavi; Andreas Coppi; Raymond A Jean; Arnar Geirsson; Wade L Schulz; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-06-03

10.  Discriminant Ability of the 3-Ounce Water Swallow Test to Detect Aspiration in Acute Postoperative Cardiac Surgical Patients.

Authors:  Justine Dallal York; Kelly Leonard; Amber Anderson; Lauren DiBiase; Eric I Jeng; Emily K Plowman
Journal:  Dysphagia       Date:  2021-07-15       Impact factor: 2.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.